IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

ANTONARELLI, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.214
AS - Asia 286
NA - Nord America 197
OC - Oceania 6
SA - Sud America 2
AF - Africa 1
Totale 1.706
Salva come PNG Salva come JPEG
Nazione #
DE - Germania 1.039
US - Stati Uniti d'America 196
CN - Cina 118
SG - Singapore 79
SE - Svezia 48
IT - Italia 46
IN - India 45
RU - Federazione Russa 28
ID - Indonesia 17
IE - Irlanda 16
FR - Francia 14
HK - Hong Kong 14
FI - Finlandia 7
GB - Regno Unito 6
NL - Olanda 4
AU - Australia 3
JP - Giappone 3
KR - Corea 3
NZ - Nuova Zelanda 3
PL - Polonia 3
TW - Taiwan 3
CL - Cile 2
AT - Austria 1
BE - Belgio 1
CA - Canada 1
CY - Cipro 1
KG - Kirghizistan 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
ZA - Sudafrica 1
Totale 1.706
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 1.026
Santa Clara 51
Singapore 51
Chandler 20
Hyderabad 18
Dublin 16
Jakarta 15
Bengaluru 14
Hong Kong 12
Beijing 11
Milan 11
New York 11
Los Angeles 9
Shanghai 9
Boston 7
Chennai 7
Oklahoma City 7
Rho 6
Paris 5
Quanzhou 5
Ashburn 4
Bari 4
Helsinki 4
Belmont 3
Fuzhou 3
Lappeenranta 3
Munich 3
Nanjing 3
Naples 3
Princeton 3
Redmond 3
Seattle 3
Taipei 3
Wuhan 3
Bollate 2
Brisbane 2
Bühl 2
Chingford 2
Fairfield 2
Gainesville 2
Groningen 2
Kent 2
Mortara 2
Pasadena 2
Ragusa 2
San Diego 2
San Jose 2
Santiago 2
Saronno 2
Umeå 2
Warsaw 2
Andover 1
Bishkek 1
Brussels 1
Bucheon-si 1
Cambridge 1
Cape Town 1
Central 1
Central Point 1
Des Moines 1
Durham 1
Erlangen 1
Ghotki 1
Guangdong 1
Guangzhou 1
Gunzenhausen 1
Hamden 1
Hangzhou 1
Herrsching am Ammersee 1
Hounslow 1
Jinan 1
Jinhua 1
Kilburn 1
London 1
Manila 1
Melbourne 1
Meta 1
Mihai Bravu 1
Montreal 1
Mumbai 1
New Haven 1
Newark 1
Nicosia 1
Nuremberg 1
Phoenix 1
Qingdao 1
Rockville 1
Saint Paul 1
Shenzhen 1
Songpa-gu 1
Southend 1
Tokyo 1
Vertemate con Minoprio 1
Vienna 1
Xiamen 1
Totale 1.434
Salva come PNG Salva come JPEG
Nome #
Management of patients with HER2-positive metastatic breast cancer after trastuzumab deruxtecan failure 145
Systemic Treatment of Ductal Carcinoma In Situ of the Breast 129
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents 119
Safety of covid-19 mrna vaccines in patients with cancer enrolled in early-phase clinical trials 108
Research and clinical landscape of bispecific antibodies for the treatment of solid malignancies 96
The Immune-related adverse event (IRAE) Likelihood Score (ILS) identifies “pure” IRAEs strongly associated with outcome in a phase I-II trial population 95
Therapeutic Cancer Vaccines Revamping: Technology Advancements and Pitfalls 91
Targeting brain metastases in breast cancer 86
Cyclin dependent kinase 4/6 inhibitors in early breast cancer: what is the role of Ki-67? 85
Harmonizing PD-L1 testing in metastatic triple negative breast cancer 84
Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review 82
Histology-agnostic approvals for antibody-drug conjugates in solid tumours: is the time ripe? 81
Investigational immunomodulatory drugs for enhancement of triple negative breast cancer (TNBC) immunotherapy: early phase development 81
The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high‐volume referral centers 80
Continuous sunitinib schedule in advanced platinum refractory thymic epithelial neoplasms: A retrospective analysis from the ThYmic MalignanciEs (TYME) Italian collaborative group 80
A set of easy and stringent criteria to identify immune-related adverse events (IrAE Scoring System, ISS) improves correlation with outcome in a phase 1-2 trial population 79
COVID-19 related risk in patients enrolled in early-phase clinical trials 77
Baseline tumor size as prognostic index in patients with cancer receiving experimental targeted agents 77
Immune-related adverse events are correlated with significantly improved outcome in a phase I trial population exposed to combination immunotherapy 76
Pembrolizumab and oral metronomic cyclophosphamide in patients with chest wall breast cancer (PERICLES): an immune-biomarker analysis of tumor infiltrating lymphocytes (TILs) and programmed cell death ligand protein 1 (PD-L1) 3
Totale 1.754
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.052
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.052
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202251 0 0 1 4 9 4 9 12 5 3 2 2
2022/2023118 8 12 21 10 12 23 7 1 6 3 9 6
2023/20241.000 16 17 29 34 72 54 163 126 61 127 151 150
2024/2025585 122 137 130 112 58 26 0 0 0 0 0 0
Totale 1.754